Conatus Pharmaceuticals Inc. (CNAT) fell -11.86% or -0.23 to $1.71. It is near to 2.59 million shares traded, which is 293.49% compare to the average total volume 883832. The market cap of CNAT is $51.75 million. The year to date change is -71.01%. The 52 week price range is from $1.52 to $7.95. Price of CNAT have changed -58.28% during last week. It have changed -62.91% over last month, -62.91% over last 3 months, -54.88% over last 6 months and -52.57% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 4.81. It is 181.29% above current price. The 200-day Moving Averages for CNAT is 4.70. It is 174.85% above current price. The 52-week High is 7.95. It is 364.91% from the current price. The 52-week Low is 1.52. It is -11.11% from current price.
There are some statistics of CNAT. It is has market cap $51.75 million. The share outstanding is 30.26 million. The average volume is 883832. The percent of top 15 Institution holding is 53.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -77.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -25.20%.